Previous Page  8 / 8
Information
Show Menu
Previous Page 8 / 8
Page Background

Page 40

Notes:

Journal of Alzheimers Disease & Parkinsonism | ISSN: 2161-0460 | Volume: 8

October 19-20, 2018 | New York, USA

5

th

International Conference on

Parkinson’s disease and Movement Disorders

The development of a multicellular three dimensional neurovascular unit model with a functional

blood- brain barrier

Goodwell Nzou

Wake Forest School of Medicine, USA

I

ncreased cerebrovascular permeability due to the blood-brain barrier (BBB) disruption is known for destabilizing brain

homeostasis, neuronal function and nutritional distribution in brain tissue. The BBB controls these functions through a

dynamic structure of tight junctions and adherent junctions formed mainly between endothelial cells. The integral selectivity

characteristic of the BBB limits therapeutic options for many neurologic diseases and disorders. Currently, very little is known

about the mechanisms that govern the dynamic nature of BBB. To date, most

in vitro

models only utilize endothelial cells,

pericytes, and astrocytes. These models neglect the role of other cell types in the brain cortex such as the neurons, microglia,

and oligodendrocytes. Thus, we seek to create a 3D spheroid model of the blood-brain barrier consisting of all major cell types

that closely recapitulate normal human brain tissue. Spheroids containing 6 cell types were maintained in static culture with

growth media exchange every other day and were fixed in 4% formaldehyde and Immunohistochemistry was performed for TJ,

AJ and cell-specific markers. Our data demonstrate the expression of TJs and AJs. Furthermore, our data on BBB functionality

assessment using MPTP, MPP+ and mercury chloride in our spheroids indicate charge selectivity through the barrier. Our

spheroid model would have applications in drug discovery and neurotoxicity and cytotoxicity testing. This model can serve as a

tool for individualized, patient-specific blood-brain barrier disease models through the use of representative cell types derived

from induced pluripotent stem cells (iPSCs).

Biography

Goodwell Nzou, born and raised in a small, remote village in Zimbabwe near the Mozambique border, Goodwell jokingly credits the snakebite to which he lost his

right leg and led him to “escape the crude village life” and to move to the city where he continued school with much bigger goals that he would have ever imagined

in the village. With a Bachelor of Science in Chemistry from Nazareth College and now studying molecular medicine, he has an unwavering commitment to playing

a role in improving health standards in underserved communities after he completes doctoral studies at Wake Forest University.

gnzou@wakehealth.edu

Goodwell Nzou, J Alzheimers Dis Parkinsonism 2018, Volume 8

DOI: 10.4172/2161-0460-C6-051